Stock DNA
Pharmaceuticals & Biotechnology
JPY 4,606 Million (Micro Cap)
6.00
NA
0.00%
-0.09
4.10%
0.77
Revenue and Profits:
Net Sales:
1,147 Million
(Quarterly Results - Mar 2026)
Net Profit:
-29 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-41.64%
0%
-41.64%
6 Months
-26.79%
0%
-26.79%
1 Year
-50.42%
0%
-50.42%
2 Years
-46.67%
0%
-46.67%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Kohjin Bio Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.70%
EBIT Growth (5y)
0.74%
EBIT to Interest (avg)
20.97
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.68
Tax Ratio
24.45%
Dividend Payout Ratio
20.36%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.69%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.87
EV to EBIT
4.81
EV to EBITDA
3.52
EV to Capital Employed
0.86
EV to Sales
0.92
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.83%
ROE (Latest)
14.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,147.40
1,287.20
-10.86%
Operating Profit (PBDIT) excl Other Income
55.60
230.90
-75.92%
Interest
9.80
9.00
8.89%
Exceptional Items
-1.40
0.00
Consolidate Net Profit
-28.60
77.60
-136.86%
Operating Profit Margin (Excl OI)
-40.10%
100.90%
-14.10%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -10.86% vs 0.18% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -136.86% vs -35.23% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
4,939.00
5,206.30
-5.13%
Operating Profit (PBDIT) excl Other Income
737.70
1,352.10
-45.44%
Interest
38.10
30.10
26.58%
Exceptional Items
10.30
-51.20
120.12%
Consolidate Net Profit
251.00
794.80
-68.42%
Operating Profit Margin (Excl OI)
69.20%
190.40%
-12.12%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is -5.13% vs 9.14% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -68.42% vs 106.44% in Mar 2025






